-
-
[1] Ringel F, Pape H, Sabel M, et al. Clinical benefit from resection of recurrent glioblastomas: Results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection[J]. Neuro Oncol, 2016, 18(1):96-104. doi: 10.1093/neuonc/nov145 [2] Herrlinger U, Schafer N, Steinbach JP, et al. Bevacizumab plus irinotecan versus temozolomide in newly diagnosed o6-methylguanine-DNA methyltransferase nonmethylated glioblastoma: The randomized glarius trial[J]. J Clin Oncol, 2016, 34(14):1611-1619. doi: 10.1200/JCO.2015.63.4691 [3] Stupp R, Wong ET, Kanner AA, et al. Novottf-100a versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase iii trial of a novel treatment modality[J]. Eur J Cancer, 2012, 48(14):2192-2202. doi: 10.1016/j.ejca.2012.04.011 -
下载:
点击查看大图
图(2)
计量
- 文章访问数: 114
- HTML全文浏览量: 34
- PDF下载量: 26
- 被引次数: 0
